
    
      This study is a pre-Market, prospective, multi-center, open-label, randomized controlled
      trial. Subjects will be 1:1 randomized and followed through 5 Years (screen, implant
      procedure(including post-procedure assessment),30-Day, 6 Months, 9 Months (primary
      endpoint_LLL), and annual assessments from 1-5 years).
    
  